KUCTC Lunch & Learn Series: Meet the Entrepreneur

Wednesday, October 13, 2021 12:00pm

Add to calendar

Please join us for a conversation with Dr. John A. Spertus, MD, Founder of Health Outcomes Science and Outcomes Instruments.


Wednesday, Oct. 13 | 12 - 1 p.m.

Register on Zoom 


Dr. Spertus founded Health Outcomes Sciences, a healthcare IT company that integrated the execution of risk models to support personalized medicine into routine clinical care with a demonstrated improvement in patient outcomes and reduction in costs. The company was sold to Terumo in February 2021.


Additionally, Dr. Spertus developed several novel assays to quantify the symptoms, function, and quality of life for patients with cardiovascular disease. Over time, two of these have emerged as the international standards for quantifying the health status of patients with coronary artery disease and heart failure. Supporting this work involved paying for numerous translations and supporting additional methodological work. To support these efforts, Outcomes Instruments was developed to license the tools to industry, investigators and clinical providers.


Dr. Spertus is a cardiologist and the Lauer/Missouri Endowed Chair and Professor of Medicine at the University of Missouri-Kansas City, where he serves as Clinical Director of Outcomes Research at Saint Luke’s Mid America Heart Institute. He is a graduate of UCSF Medical School and completed his internal medicine, cardiology and health services training at the University of Washington.


Dr. Spertus has devoted his career to improving the quality and patient-centeredness of care. His research focuses on methods for assessing patients’ health outcomes, measuring healthcare quality, and the use of information technology to guide medical decision-making based on risk-prediction models so that treatment can be safer, more cost-effective, evidence-based, and patient-centered. He developed the Seattle Angina Questionnaire (SAQ), and the Kansas City Cardiomyopathy Questionnaire (KCCQ), which have both been translated into over 95 languages each and have become the gold standards for measuring patients’ symptoms, function and quality of life in coronary artery disease and heart failure.

0 people are interested in this event

The University of Kansas Powered by the Localist Community Event Platform © All rights reserved